PHARMALYTE
Live / Registered — Registered and renewed (as of 23 Apr 2019)
What this means for you
Registered since 03 Apr 1979. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Apr 2019).
Record
- Serial number
- 73180161
- Registration number
- 1115880
- Mark type
- Word mark
- Filed
- 28 Jul 1978
- Registered
- 03 Apr 1979
- Next maintenance due
- 03 Apr 2019
- Attorney of record
- Dyan M. House
Goods and services
- Class 001 — Chemicals: CHEMICAL PRODUCTS FOR USE IN THE SEPARATION AND PURIFICATION OF ANY CHARGE CARRYING MOLECULE SUCH AS PROTEINS AND OTHER MOLECULES OF BIOLOGICAL ORIGIN AS WELL AS SYNTHETIC CHEMICALS, THESE PRODUCTS BEING CARRIER AMPHOLYTES DESIGNED FOR USE IN ISOELECTRIC FOCUSING, ISOTACHOPHORESIS AND ISO EXCHANGE CHROMATOGRAPHY
Owner
- CYTIVA SWEDEN AB, UPPSALA, SE
- GE HEALTHCARE BIO-SCIENCES AB, UPPSALA, SE
- GE HEALTHCARE BIOPROCESS R&D AB, UPPSALA, SE
- GE HEALTHCARE BIO-SCIENCES AB, Uppsala, SE
- AMERSHAM PHARMACIA BIOTECH AB, SE-751 84 UPPSALA, SE
- PHARMACIA INC., PISCATAWAY, NJ, US
Prosecution history
- 19 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Oct 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 19 Oct 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Oct 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Oct 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Oct 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Sept 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Sept 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Sept 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Feb 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Feb 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Apr 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED